当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 现金流量表

博济医药

(300404)

  

流通市值:27.07亿  总市值:37.18亿
流通股本:2.81亿   总股本:3.86亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金578,586,582.28384,396,444.29175,844,429.62680,449,708.78
  收到其他与经营活动有关的现金37,794,982.8723,992,185.2913,519,862.4646,414,128.37
  经营活动现金流入小计616,381,565.15408,388,629.58189,364,292.08726,863,837.15
  购买商品、接受劳务支付的现金290,206,511.22183,515,192.3883,683,514.53292,605,111.08
  支付给职工以及为职工支付的现金254,184,463.89161,596,469.8180,047,494.51324,269,736.97
  支付的各项税费28,928,772.4918,023,165.117,563,464.6638,957,921.1
  支付其他与经营活动有关的现金35,266,842.6524,008,534.859,241,122.7644,250,680.19
  经营活动现金流出小计608,586,590.25387,143,362.15180,535,596.46700,083,449.34
  经营活动产生的现金流量净额7,794,974.921,245,267.438,828,695.6226,780,387.81
二、投资活动产生的现金流量:
  收回投资收到的现金5,499,117.814,749,117.81749,117.8119,347,918.46
  取得投资收益收到的现金1,075,198.42839,399.97208,664.113,020,785.72
  处置固定资产、无形资产和其他长期资产收回的现金净额2,7502,7501,370456,620
  收到的其他与投资活动有关的现金349,700,000272,000,00055,000,000679,100,000
  投资活动现金流入小计356,277,066.23277,591,267.7855,959,151.92701,925,324.18
  购建固定资产、无形资产和其他长期资产支付的现金14,842,659.399,495,812.363,932,554.1129,352,753.92
  投资支付的现金1,280,4301,280,430-44,125,000
  支付其他与投资活动有关的现金491,600,000404,100,000182,100,000695,300,000
  投资活动现金流出小计507,723,089.39414,876,242.36186,032,554.11768,777,753.92
  投资活动产生的现金流量净额-151,446,023.16-137,284,974.58-130,073,402.19-66,852,429.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金25,588,613.1114,044,736.465,840,171.324,203,927.32
  其中:子公司吸收少数股东投资收到的现金---849,765.37
  取得借款收到的现金43,189,70043,189,7001,000,0008,135,356.13
  收到其他与筹资活动有关的现金170,559.96126,445.3840,795.76395,480.53
  筹资活动现金流入小计68,948,873.0757,360,881.846,880,967.0812,734,763.98
  偿还债务支付的现金42,549,914.1641,954,914.161,000,00072,289,925.66
  分配股利、利润或偿付利息支付的现金5,332,110.89720,315.45378,656.968,458,887.08
  其中:子公司支付给少数股东的股利、利润---875,000
  支付其他与筹资活动有关的现金2,473,663.941,971,441.12983,990.9618,969,471.71
  筹资活动现金流出小计50,355,688.9944,646,670.732,362,647.9299,718,284.45
  筹资活动产生的现金流量净额18,593,184.0812,714,211.114,518,319.16-86,983,520.47
四、汇率变动对现金及现金等价物的影响-333,707.79-119,795.01-41,860.08457,881.81
五、现金及现金等价物净增加额-125,391,571.97-103,445,291.05-116,768,247.49-126,597,680.59
  加:期初现金及现金等价物余额268,558,630.83268,558,630.83268,558,630.83395,156,311.42
  期末现金及现金等价物余额143,167,058.86165,113,339.78151,790,383.34268,558,630.83
补充资料:
  净利润-17,560,429.1-30,657,467.22
  资产减值准备-13,366,516.57-23,892,167.61
  固定资产和投资性房地产折旧-12,437,222.4-23,532,955.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-12,437,222.4-23,532,955.45
  无形资产摊销-567,819.13-989,054.98
  长期待摊费用摊销-6,073,762.7-3,661,888.7
  处置固定资产、无形资产和其他长期资产的损失---213,678.75
  固定资产报废损失-4,491.93-76,873.43
  公允价值变动损失--914,273.99--1,058,690.69
  财务费用-901,318.79-3,186,407.41
  投资损失--301,173.62--1,979,446.48
  递延所得税--4,488,306.8--19,099,725.59
  其中:递延所得税资产减少--4,677,422.95--18,209,077.67
    递延所得税负债增加-189,116.15--890,647.92
  存货的减少--56,271,127.01-8,235,961.49
  经营性应收项目的减少--47,644,764.79--108,310,906.97
  经营性应付项目的增加-78,962,251.88-60,078,199.36
  不涉及现金收支的投资和筹资活动金额其他项目-526,664.74-2,978,209.65
  现金的期末余额-165,113,339.78-268,558,630.83
  减:现金的期初余额-268,558,630.83-395,156,311.42
  现金及现金等价物的净增加额--103,445,291.05--126,597,680.59
公告日期2025-10-292025-08-272025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑